Xeomin, the latest botulinum toxin injectable to receive FDA approval for use on frown lines, was featured on a recent episode of ABC’s "The Doctors."
Merz’s Xeomin offers patients a third choice — in addition to Botox and Dysport — for those wanting botulinum toxin injections. Xeomin works in the same way as the other two do, with a few differences.
New York dermatologist Dr. Neil Sadick explains that the major difference is in the manufacturing process. All proteins are removed from Xeomin, so potentially there could be less incidence of adverse events that could occur with this toxin, according to Dr. Sadick.
Patients are happy with Xeomin, according to Dr. Sadick, who says the results are very natural, and like other toxins, Xeomin has a very low side effect profile.
He said that about 3 million toxin treatments are performed each year in the United States.
People also viewed
Learn More About the Risks and Benefits of Laser Resurfacing
2021-07-08T22:08:43+00:00